You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 247 No. 7, February 19, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (47)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Recurrent Incapacitating Mucosal Ulcerations

A Prodrome of the Hypereosinophilic Syndrome

Kristin M. Leiferman, MD; J. Desmond O'Duffy, MD; Harold O. Perry, MD; Philip R. Greipp, MD; Emilio R. Giuliani, MD; Gerald J. Gleich, MD

JAMA. 1982;247(7):1018-1020.


Abstract

The hypereosinophilic syndrome is a multisystem disease characterized by infiltration of eosinophils in bone marrow, heart, and other organs. Cutaneous involvement occurs, but usually it appears late in the disease and is of less importance than the cardiac and other organ involvement. We describe two patients with the hypereosinophilic syndrome (HES) in whom the initial manifestations of the disease were recurrent, severe mucosal ulcers involving the mouth and genitalia. In both patients, the mucosal involvement antedated the cardiac manifestations of the disease, and in both, the disease was refractory to treatment.

(JAMA 1982;247:1018-1020)



Author Affiliations

From the Departments of Dermatology (Drs Leiferman and Perry) and Internal Medicine (Drs O'Duffy, Greipp, Giuliani, and Gleich), the Mayo Clinic and Mayo Foundation, Rochester, Minn.


Footnotes

Reprint requests to Department of Dermatology, Mayo Clinic, Rochester, MN 55901 (Dr Leiferman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Eosinophil Ribonucleases and Their Cutaneous Lesion-Forming Activity
Plager et al.
J. Immunol. 2009;183:4013-4020.
ABSTRACT | FULL TEXT  

Blood Eosinophilia: A New Paradigm in Disease Classification, Diagnosis, and Treatment
Tefferi
Mayo Clin Proc. 2005;80:75-83.
ABSTRACT  

The FIP1L1-PDGFR{alpha} fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management
Gotlib et al.
Blood 2004;103:2879-2891.
ABSTRACT | FULL TEXT  

The Idiopathic Hypereosinophilic Syndrome
Weller and Dvorak
Arch Dermatol 1996;132:583-585.
ABSTRACT  

Recurrent Cutaneous Necrotizing Eosinophilic Vasculitis: A Novel Eosinophil-Mediated Syndrome
Chen et al.
Arch Dermatol 1994;130:1159-1166.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.